Bank of America’s SELLAS Life Sciences SLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.7K | Buy |
34,579
+33,957
| +5,459% | +$74.4K | ﹤0.01% | 5663 |
|
|
2025
Q1 | $672 | Buy |
622
+50
| +9% | +$54 | ﹤0.01% | 6426 |
|
|
2024
Q4 | $595 | Buy |
572
+46
| +9% | +$48 | ﹤0.01% | 6451 |
|
|
2024
Q3 | $658 | Sell |
526
-51
| -9% | -$64 | ﹤0.01% | 6394 |
|
|
2024
Q2 | $687 | Buy |
+577
| New | +$687 | ﹤0.01% | 6398 |
|
|
2024
Q1 | – | Sell |
-42
| Closed | -$44 | – | 7031 |
|
|
2023
Q4 | $44 | Buy |
+42
| New | +$44 | ﹤0.01% | 6550 |
|
|
2023
Q1 | – | Sell |
-48
| Closed | -$114 | – | 7229 |
|
|
2022
Q4 | $114 | Buy |
+48
| New | +$114 | ﹤0.01% | 6820 |
|
|
2022
Q3 | – | Sell |
-24,268
| Closed | -$54K | – | 7154 |
|
|
2022
Q2 | $54K | Buy |
24,268
+2,612
| +12% | +$5.81K | ﹤0.01% | 6005 |
|
|
2022
Q1 | $145K | Sell |
21,656
-10,144
| -32% | -$67.9K | ﹤0.01% | 5886 |
|
|
2021
Q4 | $176K | Sell |
31,800
-12,091
| -28% | -$66.9K | ﹤0.01% | 5762 |
|
|
2021
Q3 | $403K | Buy |
+43,891
| New | +$403K | ﹤0.01% | 5001 |
|
|
2021
Q2 | – | Sell |
-400
| Closed | -$3K | – | 7131 |
|
|
2021
Q1 | $3K | Hold |
400
| – | – | ﹤0.01% | 6479 |
|
|
2020
Q4 | $2K | Buy |
+400
| New | +$2K | ﹤0.01% | 6167 |
|
|
2020
Q2 | – | Sell |
-1,185
| Closed | -$2K | – | 6381 |
|
|
2020
Q1 | $2K | Buy |
+1,185
| New | +$2K | ﹤0.01% | 6012 |
|
|
2018
Q4 | – | Sell |
-188
| Closed | – | – | 6482 |
|
|
2018
Q3 | $0 | Buy |
+188
| New | – | ﹤0.01% | 6594 |
|
|
2017
Q4 | – | Sell |
-500
| Closed | – | – | 6300 |
|
|
2017
Q3 | $0 | Buy |
500
+489
| +4,445% | – | ﹤0.01% | 6334 |
|
|
2017
Q2 | $0 | Sell |
11
-8,013
| -100% | – | ﹤0.01% | 6237 |
|
|
2017
Q1 | $5K | Buy |
8,024
+6,540
| +441% | +$4.08K | ﹤0.01% | 5908 |
|
|
2016
Q4 | $3K | Buy |
+1,484
| New | +$3K | ﹤0.01% | 5991 |
|